Skip to main content
EVRRF logo

Molecule Holdings Inc. (EVRRF) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0025 $0.00 (0.00%)
Vol: 1.0K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Molecule Holdings Inc. (EVRRF) trades at $0.0025. Molecule Holdings Inc. is a Canadian company focused on the production and co-packing of cannabis-infused beverages. Their products are available under the PHRESH, embody, and CANAJO brands. Sector: Healthcare.

Price as of · Last analyzed: Mar 17, 2026
Molecule Holdings Inc. is a Canadian company focused on the production and co-packing of cannabis-infused beverages. Their products are available under the PHRESH, embody, and CANAJO brands.

Analyst Coverage for EVRRF: EVRRF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the EVRRF film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Molecule Holdings Inc. (EVRRF) Healthcare & Pipeline Overview

CEODavid Reingold
HeadquartersLansdowne, CA
IPO Year2020

Molecule Holdings Inc. is a Canadian beverage company specializing in the cannabis-infused sector, offering brands like PHRESH, embody, and CANAJO. Operating within the evolving Canadian cannabis market, the company faces competition and regulatory hurdles while focusing on production and co-packing strategies to establish its market presence.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for EVRRF?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Molecule Holdings Inc. presents a speculative investment opportunity within the emerging Canadian cannabis-infused beverage market. The company's focus on both branded product sales and co-packing services offers diversified revenue streams. However, the company's negative profit margin of -230.8% and gross margin of -54.6% indicate significant challenges in achieving profitability. The company's small market capitalization and OTC listing add to the risk profile. Future growth hinges on successful brand development, efficient operations, and navigating the evolving regulatory landscape of the Canadian cannabis market. Investors should carefully consider the company's financial performance, competitive positioning, and the inherent risks associated with the cannabis industry before making investment decisions. The negative beta of -0.46 suggests a potential inverse correlation with the broader market, but this may be influenced by the company's specific challenges.

Based on FMP financials and quantitative analysis

EVRRF Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Molecule Holdings Inc. operates in the cannabis-infused beverage market in Canada.

  • The company's brands include PHRESH, embody, and CANAJO.
  • Molecule Holdings Inc. provides co-packing services to other cannabis companies.
  • The company's profit margin is -230.8%, indicating significant losses.
  • The company's gross margin is -54.6%, reflecting challenges in production costs and pricing.

Who Are EVRRF's Competitors?

EVRRF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
AVCNF Avicanna Inc. $0.07 +1.43% $8.93M —
CRVW CareView Communications, Inc. $0.03 -25.00% $17.5M —
CWBHF Charlotte's Web Holdings, Inc. $0.27 -3.68% $73.1M —
SNOA Sonoma Pharmaceuticals, Inc. $1.24 -0.80% $5.94M —
AKAN Akanda Corp. $1.98 -10.41% —
BFRI Biofrontera Inc. $1.01 -2.40% $13.0M —
COSM COSM $0.38 -1.58% $20.7M —
QNTM Quantum BioPharma Ltd. $3.44 +0.44% $22.0M —

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are EVRRF's Key Strengths?

Established brands in the cannabis-infused beverage market.

  • Co-packing services provide diversified revenue streams.
  • Focus on a specific niche within the cannabis industry.
  • Experienced management team with expertise in beverage production and cannabis regulations.

What Are EVRRF's Weaknesses?

Negative profit and gross margins indicate financial challenges.

  • Small market capitalization and OTC listing increase investment risk.
  • Limited brand recognition compared to larger competitors.
  • Dependence on the evolving regulatory landscape of the Canadian cannabis market.

What Are the Key Risks for EVRRF?

Financial-distress signal — its Altman Z-Score of -12.10 sits in the distress zone (elevated bankruptcy risk).

  • Intense competition from larger cannabis companies with greater resources.
  • Stringent regulations and licensing requirements could hinder growth.
  • Fluctuations in cannabis prices and supply could impact profitability.
  • Negative profit and gross margins indicate financial instability.
  • Changes in consumer preferences and market trends could affect demand for the company's products.

What Are EVRRF's Competitive Advantages?

  • Brand portfolio (PHRESH, embody, CANAJO) provides some differentiation in the market.
  • Co-packing services offer a diversified revenue stream.
  • Early mover advantage in the emerging Canadian cannabis-infused beverage market.

What Does EVRRF Do?

Molecule Holdings Inc., based in Lansdowne, Canada, is a producer and co-packer of cannabis-infused beverages. The company operates within the Canadian cannabis market, focusing on the development, manufacturing, and distribution of cannabis-infused drinks. Molecule Holdings offers its beverage products under a portfolio of brands, including PHRESH, embody, and CANAJO. These brands target different consumer segments within the cannabis beverage market, offering a range of flavors and formulations. The company's business model centers around both producing its own branded products and providing co-packing services to other cannabis companies. This dual approach allows Molecule Holdings to generate revenue through direct sales of its brands and by leveraging its production infrastructure to support other businesses in the cannabis industry. The company's focus on cannabis-infused beverages positions it within a niche segment of the broader cannabis market, which includes dried cannabis, oils, edibles, and other cannabis-derived products. As the Canadian cannabis market continues to evolve, Molecule Holdings aims to establish itself as a key player in the beverage sector through product innovation, strategic partnerships, and efficient production capabilities. The company navigates a complex regulatory environment and evolving consumer preferences to capitalize on the growth potential of the cannabis-infused beverage market.

What Products and Services Does EVRRF Offer?

  • Produces cannabis-infused beverages.
  • Co-packs cannabis-infused beverages for other companies.
  • Offers beverages under the PHRESH brand.
  • Offers beverages under the embody brand.
  • Offers beverages under the CANAJO brand.
  • Focuses on the Canadian cannabis market.

How Does EVRRF Make Money?

  • Generates revenue from the sale of its branded cannabis-infused beverages.
  • Provides co-packing services to other cannabis companies, generating revenue from production fees.
  • Focuses on building brand recognition and market share within the Canadian cannabis beverage market.

What Industry Does EVRRF Operate In?

Molecule Holdings Inc. operates within the rapidly evolving Canadian cannabis industry, specifically targeting the infused beverage segment. This market is characterized by increasing consumer interest in alternative cannabis consumption methods beyond traditional smoking. The industry is subject to stringent regulations and licensing requirements, which impact production, distribution, and marketing activities. Competition includes other cannabis beverage producers like AVCNF (Acreage Holdings Inc.), CAAOF (Canopy Growth Corporation), CHOOF (Choom Holdings Inc.), CRVW (Cronos Group Inc.), and CWBHF (Charlotte's Web Holdings, Inc.), as well as established beverage companies exploring cannabis-infused products. Market trends include the development of innovative flavors, formulations, and delivery methods to cater to diverse consumer preferences. The overall cannabis market is projected to experience continued growth, driven by increasing legalization and acceptance, creating opportunities for companies like Molecule Holdings to expand their market share.

Who Are EVRRF's Key Customers?

  • Consumers of cannabis-infused beverages in Canada.
  • Other cannabis companies seeking co-packing services.
  • Retailers and distributors of cannabis products in Canada.
Model self-rating on this text: 79% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage
F-Score 5/9

Financial Health

Molecule Holdings Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -12.10 places it in the distress zone, a signal of elevated financial risk.

ROE 297%

Key Financial Metrics

Return on equity for Molecule Holdings Inc. stands at 297.3%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.17 means current liabilities exceed short-term assets, a liquidity point worth watching.

Company Profile

Molecule Holdings Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Lansdowne, Canada.

EVRRF Financials

Fundamental Snapshot

Return on Equity (TTM)
+297.3%
Current Ratio
0.2

Based on FMP financials and quantitative analysis

EVRRF Latest News

No recent news available for EVRRF.

EVRRF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for EVRRF.

Price Targets

Wall Street price target analysis for EVRRF.

EVRRF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for EVRRF; grades run from A+ (80-100) to F (below 30).

Leadership: David Reingold

CEO

David Reingold is the CEO of Molecule Holdings Inc. His background includes experience in the beverage industry and a focus on emerging markets. He has been involved in the development and launch of several beverage brands. Reingold's expertise lies in brand strategy, product development, and market penetration. He is responsible for leading Molecule Holdings' strategic direction and overseeing its operations in the Canadian cannabis market. His experience is geared towards navigating the regulatory environment and building a competitive presence in the cannabis-infused beverage sector.

Track Record: Under David Reingold's leadership, Molecule Holdings has focused on expanding its brand portfolio and establishing co-packing partnerships. Key milestones include the launch of the PHRESH, embody, and CANAJO brands, as well as securing agreements with other cannabis companies for co-packing services. Reingold has emphasized product innovation and market expansion to drive revenue growth. The company's focus on the cannabis-infused beverage market reflects his strategic vision for capitalizing on emerging consumer trends.

EVRRF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Molecule Holdings Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information, lower liquidity, and greater price volatility. This tier is often populated by shell companies, bankrupt entities, or companies with questionable operations.

  • OTC Tier: OTC Other
Liquidity: Liquidity for EVRRF is likely very limited given its OTC Other listing and small market capitalization. Bid-ask spreads are expected to be wide, and it may be difficult to buy or sell shares without significantly impacting the price. Investors should exercise extreme caution due to the potential for illiquidity and price manipulation. Trading volume is likely low, making it challenging to establish or exit positions quickly.
OTC Risk Factors:
  • Limited financial disclosure increases the risk of investing in EVRRF.
  • Low liquidity can make it difficult to buy or sell shares at desired prices.
  • The OTC Other tier is associated with higher risks of fraud and manipulation.
  • The company's small market capitalization makes it more vulnerable to price volatility.
  • The cannabis industry is subject to evolving regulations and licensing requirements.
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the background and experience of the management team.
  • Assess the company's competitive positioning and market share.
  • Evaluate the company's compliance with cannabis regulations.
  • Monitor trading volume and price volatility.
  • Understand the company's business model and revenue streams.
  • Consult with a financial advisor before investing.
Legitimacy Signals:
  • The company has established brands in the cannabis-infused beverage market.
  • The company provides co-packing services to other cannabis companies.
  • The company operates within the regulated Canadian cannabis market.

Molecule Holdings Inc. Healthcare Stock: Key Questions Answered

What do analysts say about EVRRF stock?

As of 2026-03-17, there is no available analyst coverage for EVRRF stock. The company's small market capitalization and OTC listing may limit analyst interest. Key valuation metrics, such as the P/E ratio of -0.11, indicate that the company is not currently profitable.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is limited due to the company's OTC listing and disclosure status.
  • Analyst coverage is not available for this company.
  • The cannabis industry is subject to evolving regulations and market trends.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis